Decoy Therapeutics Inc. Debt Instrument, Face Amount
Decoy Therapeutics Inc. (DCOY) had Debt Instrument, Face Amount of $900.00 thousand as of 2020-07-31, per its 10-K filed 2021-03-18.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2021-03-18
- 2020-07-31: Debt Instrument, Face Amount $900.00K.
- 2019-07-31: Debt Instrument, Face Amount $900.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-07-31 | $900.00K 10-K · filed 2021-03-18 |
| 2019-07-31 | $900.00K 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |